smscall
logo
Medical Devices & Consumables

Published On: Feb 11, 2025

Global Spine Biologics Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

  • starstarstarstarstar
  • 0
  • 0 Reviews
  • 191 Pages
  • 0 Views

Version Type

$3,950.00

Summary
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
According to APO Research, The global Spine Biologics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Spine Biologics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Spine Biologics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Spine Biologics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Spine Biologics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Spine Biologics include Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, Zimmer Biomet, Orthofix International, Globus Medical, alphatec spine and K2M, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Spine Biologics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Spine Biologics, also provides the sales of main regions and countries. Of the upcoming market potential for Spine Biologics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Spine Biologics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Spine Biologics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Spine Biologics sales, projected growth trends, production technology, application and end-user industry.
Spine Biologics Segment by Company
Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Spine Biologics Segment by Type
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
BMAC (Bone Marrow Aspirate Concentrate)
Spine Biologics Segment by Application
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion
Others
Spine Biologics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spine Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Spine Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spine Biologics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Spine Biologics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Spine Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Spine Biologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Spine Biologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Table 1:Spine Biologics Industry Trends
Table 2:Spine Biologics Industry Drivers
Table 3:Spine Biologics Industry Opportunities and Challenges
Table 4:Spine Biologics Industry Restraints
Table 5:Global Spine Biologics Revenue by Manufacturers (US$ Million) & (2020-2025)
Table 6:Global Spine Biologics Revenue Market Share by Manufacturers (2020-2025)
Table 7:Global Spine Biologics Sales by Manufacturers (K Units) & (2020-2025)
Table 8:Global Spine Biologics Sales Market Share by Manufacturers
Table 9:Global Spine Biologics Average Sales Price (USD/Unit) of Manufacturers (2020-2025)
Table 10:Global Spine Biologics Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
Table 11:Global Spine Biologics Key Manufacturers Manufacturing Sites & Headquarters
Table 12:Global Spine Biologics Manufacturers, Product Type & Application
Table 13:Global Spine Biologics Manufacturers Establishment Date
Table 14:Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15:Global Spine Biologics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2024)
Table 16:Major Manufacturers of Bone Graft
Table 17:Major Manufacturers of Bone Graft Substitute
Table 18:Major Manufacturers of Platelet Rich Plasma (PRP)
Table 19:Major Manufacturers of BMAC (Bone Marrow Aspirate Concentrate)
Table 20:Global Spine Biologics Sales by Type 2020 VS 2024 VS 2031 (K Units)
Table 21:Global Spine Biologics Sales by Type (2020-2025) & (K Units)
Table 22:Global Spine Biologics Sales by Type (2026-2031) & (K Units)
Table 23:Global Spine Biologics Sales Market Share by Type (2020-2025)
Table 24:Global Spine Biologics Sales Market Share by Type (2026-2031)
Table 25:Global Spine Biologics Revenue by Type 2020 VS 2024 VS 2031 (K Units)
Table 26:Global Spine Biologics Revenue by Type (2020-2025) & (K Units)
Table 27:Global Spine Biologics Revenue by Type (2026-2031) & (K Units)
Table 28:Global Spine Biologics Revenue Market Share by Type (2020-2025)
Table 29:Global Spine Biologics Revenue Market Share by Type (2026-2031)
Table 30:Major Manufacturers of Anterior Cervical Discectomy and Fusion
Table 31:Major Manufacturers of Posterior Lumbar Interbody Fusion
Table 32:Major Manufacturers of Others
Table 33:Global Spine Biologics Sales by Application 2020 VS 2024 VS 2031 (K Units)
Table 34:Global Spine Biologics Sales by Application (2020-2025) & (K Units)
Table 35:Global Spine Biologics Sales by Application (2026-2031) & (K Units)
Table 36:Global Spine Biologics Sales Market Share by Application (2020-2025)
Table 37:Global Spine Biologics Sales Market Share by Application (2026-2031)
Table 38:Global Spine Biologics Revenue by Application 2020 VS 2024 VS 2031 (K Units)
Table 39:Global Spine Biologics Revenue by Application (2020-2025) & (K Units)
Table 40:Global Spine Biologics Revenue by Application (2026-2031) & (K Units)
Table 41:Global Spine Biologics Revenue Market Share by Application (2020-2025)
Table 42:Global Spine Biologics Revenue Market Share by Application (2026-2031)
Table 43:Global Spine Biologics Sales by Region: 2020 VS 2024 VS 2031 (K Units)
Table 44:Global Spine Biologics Sales by Region (2020-2025) & (K Units)
Table 45:Global Spine Biologics Sales Market Share by Region (2020-2025)
Table 46:Global Spine Biologics Sales Forecasted by Region (2026-2031) & (K Units)
Table 47:Global Spine Biologics Sales Forecasted Market Share by Region (2026-2031)
Table 48:North America Spine Biologics Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 49:North America Spine Biologics Sales by Country (2020-2025) & (K Units)
Table 50:North America Spine Biologics Sales by Country (2026-2031) & (K Units)
Table 51:Europe Spine Biologics Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 52:Europe Spine Biologics Sales by Country (2020-2025) & (K Units)
Table 53:Europe Spine Biologics Sales by Country (2026-2031) & (K Units)
Table 54:Asia Pacific Spine Biologics Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 55:Asia Pacific Spine Biologics Sales by Country (2020-2025) & (K Units)
Table 56:Asia Pacific Spine Biologics Sales by Country (2026-2031) & (K Units)
Table 57:South America, Middle East and Africa Spine Biologics Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 58:South America, Middle East and Africa Spine Biologics Sales by Country (2020-2025) & (K Units)
Table 59:South America, Middle East and Africa Spine Biologics Sales by Country (2026-2031) & (K Units)
Table 60:Global Spine Biologics Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 61:Global Spine Biologics Revenue by Region (2020-2025) & (US$ Million)
Table 62:Global Spine Biologics Revenue by Region (2026-2031) & (US$ Million)
Table 63:Global Spine Biologics Revenue Market Share by Region (2020-2025)
Table 64:Global Spine Biologics Revenue Market Share by Region (2026-2031)
Table 65:Medtronic Company Information
Table 66:Medtronic Business Overview
Table 67:Medtronic Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 68:Medtronic Spine Biologics Product Portfolio
Table 69:Medtronic Recent Development
Table 70:Depuy Synthes Company Information
Table 71:Depuy Synthes Business Overview
Table 72:Depuy Synthes Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 73:Depuy Synthes Spine Biologics Product Portfolio
Table 74:Depuy Synthes Recent Development
Table 75:Stryker Corporation Company Information
Table 76:Stryker Corporation Business Overview
Table 77:Stryker Corporation Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 78:Stryker Corporation Spine Biologics Product Portfolio
Table 79:Stryker Corporation Recent Development
Table 80:Nuvasive Company Information
Table 81:Nuvasive Business Overview
Table 82:Nuvasive Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83:Nuvasive Spine Biologics Product Portfolio
Table 84:Nuvasive Recent Development
Table 85:Zimmer Biomet Company Information
Table 86:Zimmer Biomet Business Overview
Table 87:Zimmer Biomet Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88:Zimmer Biomet Spine Biologics Product Portfolio
Table 89:Zimmer Biomet Recent Development
Table 90:Orthofix International Company Information
Table 91:Orthofix International Business Overview
Table 92:Orthofix International Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93:Orthofix International Spine Biologics Product Portfolio
Table 94:Orthofix International Recent Development
Table 95:Globus Medical Company Information
Table 96:Globus Medical Business Overview
Table 97:Globus Medical Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98:Globus Medical Spine Biologics Product Portfolio
Table 99:Globus Medical Recent Development
Table 100:alphatec spine Company Information
Table 101:alphatec spine Business Overview
Table 102:alphatec spine Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103:alphatec spine Spine Biologics Product Portfolio
Table 104:alphatec spine Recent Development
Table 105:K2M Company Information
Table 106:K2M Business Overview
Table 107:K2M Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108:K2M Spine Biologics Product Portfolio
Table 109:K2M Recent Development
Table 110:Exactech Company Information
Table 111:Exactech Business Overview
Table 112:Exactech Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113:Exactech Spine Biologics Product Portfolio
Table 114:Exactech Recent Development
Table 115:Wright Medical Technology Company Information
Table 116:Wright Medical Technology Business Overview
Table 117:Wright Medical Technology Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118:Wright Medical Technology Spine Biologics Product Portfolio
Table 119:Wright Medical Technology Recent Development
Table 120:X-Spine Company Information
Table 121:X-Spine Business Overview
Table 122:X-Spine Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123:X-Spine Spine Biologics Product Portfolio
Table 124:X-Spine Recent Development
Table 125:Nutech Company Information
Table 126:Nutech Business Overview
Table 127:Nutech Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128:Nutech Spine Biologics Product Portfolio
Table 129:Nutech Recent Development
Table 130:Arthrex Company Information
Table 131:Arthrex Business Overview
Table 132:Arthrex Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133:Arthrex Spine Biologics Product Portfolio
Table 134:Arthrex Recent Development
Table 135:Key Raw Materials
Table 136:Raw Materials Key Suppliers
Table 137:Spine Biologics Distributors List
Table 138:Spine Biologics Customers List
Table 139:Research Programs/Design for This Report
Table 140:Authors List of This Report
Table 141:Secondary Sources
Table 142:Primary Sources
Figure 1:Spine Biologics Product Image
Figure 2:Global Spine Biologics Market Size (US$ Million), 2020 VS 2024 VS 2031
Figure 3:Global Spine Biologics Market Size (2020-2031) & (US$ Million)
Figure 4:Global Spine Biologics Sales (2020-2031) & (K Units)
Figure 5:Global Spine Biologics Average Price (USD/Unit) & (2020-2031)
Figure 6:Global Top 5 and 10 Spine Biologics Players Market Share by Revenue in 2023
Figure 7:Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8:Bone Graft Image
Figure 9:Bone Graft Substitute Image
Figure 10:Platelet Rich Plasma (PRP) Image
Figure 11:BMAC (Bone Marrow Aspirate Concentrate) Image
Figure 12:Global Spine Biologics Sales by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 13:Global Spine Biologics Sales Market Share 2020 VS 2024 VS 2031
Figure 14:Global Spine Biologics Sales Market Share by Type (2020-2031)
Figure 15:Global Spine Biologics Revenue by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 16:Global Spine Biologics Revenue Market Share 2020 VS 2024 VS 2031
Figure 17:Global Spine Biologics Revenue Market Share by Type (2020-2031)
Figure 18:Anterior Cervical Discectomy and Fusion Image
Figure 19:Posterior Lumbar Interbody Fusion Image
Figure 20:Others Image
Figure 21:Global Spine Biologics Sales by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 22:Global Spine Biologics Sales Market Share 2020 VS 2024 VS 2031
Figure 23:Global Spine Biologics Sales Market Share by Application (2020-2031)
Figure 24:Global Spine Biologics Revenue by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 25:Global Spine Biologics Revenue Market Share 2020 VS 2024 VS 2031
Figure 26:Global Spine Biologics Revenue Market Share by Application (2020-2031)
Figure 27:North America Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 28:North America Spine Biologics Sales Market Share by Country (2020-2031)
Figure 29:U.S. Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 30:Canada Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 31:Mexico Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 32:Europe Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 33:Europe Spine Biologics Sales Market Share by Country (2020-2031)
Figure 34:Germany Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 35:France Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 36:U.K. Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 37:Italy Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 38:Netherlands Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 39:Asia Pacific Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 40:Asia Pacific Spine Biologics Sales Market Share by Country (2020-2031)
Figure 41:China Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 42:Japan Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 43:South Korea Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 44:Southeast Asia Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 45:India Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 46:Australia Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 47:South America, Middle East and Africa Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 48:South America, Middle East and Africa Spine Biologics Sales Market Share by Country (2020-2031)
Figure 49:Brazil Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 50:South Africa Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 51:Saudi Arabia Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 52:Turkey Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 53:Argentina Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 54:UAE Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 55:Egypt Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 56:Chile Spine Biologics Sales and Growth Rate (2020-2031) & (K Units)
Figure 57:Global Spine Biologics Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 58:Global Spine Biologics Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 59:North America Spine Biologics Revenue (2020-2031) & (US$ Million)
Figure 60:North America Spine Biologics Revenue Share by Country: 2020 VS 2024 VS 2031
Figure 61:Europe Spine Biologics Revenue (2020-2031) & (US$ Million)
Figure 62:Europe Spine Biologics Revenue Share by Country: 2020 VS 2024 VS 2031
Figure 63:Asia-Pacific Spine Biologics Revenue (2020-2031) & (US$ Million)
Figure 64:Asia-Pacific Spine Biologics Revenue Share by Country: 2020 VS 2024 VS 2031
Figure 65:South America, Middle East and Africa Spine Biologics Revenue (2020-2031) & (US$ Million)
Figure 66:South America, Middle East and Africa Spine Biologics Revenue Share by Country: 2020 VS 2024 VS 2031
Figure 67:Spine Biologics Value Chain
Figure 68:Manufacturing Cost Structure
Figure 69:Spine Biologics Production Mode & Process
Figure 70:Direct Comparison with Distribution Share
Figure 71:Distributors Profiles
Figure 72:Years Considered
Figure 73:Research Process
Figure 74:Key Executives Interviewed

Request a Sample

Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Report Cover

Medical Devices & Consumables

Global Spine Biologics Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

0| 0 Reviews

Pages: 191

Complete Your Request

Select Country
Phone

Customer reviews

  • starstarstarstarstar
  • 0 out of 5
  • 0 Reviews

5

star rating

4

star rating

3

star rating

2

star rating

1

star rating

No Rating Review Exist.

Write Review
  • starstarstarstarstar

Suggested Report

View More

No data found.